Asper Flex Cream
FDA Label NDC 71399-0049

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Akron Pharma Inc. for the product Asper Flex (NDC 71399-0049). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient, purpose, uses, warnings, otc - do not use, directions, for external use only, do not use, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Directions

  • Adult and children 2 years and older: Apply externally to the affected area up to 3 to 4 times a day.
  • Children under 2 years of age: Consult a doctor.

Do Not Use

  • in or near the eyes
  • in large quantities, particularly over raw or blistered areas

Stop Use And Ask A Doctor If

  • allergic reaction occurs
  • condition worsens or does not improve within 7 days
  • symptoms clear up and return within a few days
  • redness, irritation, swelling, pain or other symptoms begin or increase

Keep Out Of Reach Of Children. If Swallowed, Get Medical Help Or Contact A Poison Control Center Right Away.

Inactive Ingredients

Benzyl Alcohol, Carbopol 940, Hydrogenated Lecithin, Polysorbate 80, Propylene Glycol, Puried Water, Trolamine and Vitamin E Acetate.

Package Label.Principal Display Panel

4-5-1 (Lidocaine4 5g Page 1)

4-5-1 (Lidocaine4 5g Page 1)

4-5-2 (Lidocaine4 5g Page 2)

4-5-2 (Lidocaine4 5g Page 2)

4-5-3 (Lidocaine4 15g Page 1)

4-5-3 (Lidocaine4 15g Page 1)

4-5-4 (Lidocaine4 15g Page 2)

4-5-4 (Lidocaine4 15g Page 2)

4-5-5 (Lidocaine4 30gm Page 1)

4-5-5 (Lidocaine4 30gm Page 1)

4-5-6 (Lidocaine4 30gm Page 2)

4-5-6 (Lidocaine4 30gm Page 2)

* Please review the disclaimer below.